Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Vossenkämper

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Archivum Immunologiae Et Therapiae Experimentalis|July 27, 2011
Transitional B cells: how well are the checkpoints for specificity understood?Anna Vossenkämper, Jo Spencer
Journal of Inflammation (London, England)|May 5, 2011
Always one step ahead: How pathogenic bacteria use the type III secretion system to manipulate the intestinal mucosal immune systemAnna Vossenkämper, Thomas T Macdonald, Olivier Marchès
Journal of Pediatric Gastroenterology and Nutrition|December 3, 2011
Colonic lymphoid nodular hyperplasia in an adolescentAnna Vossenkämper, Asma Fikree, Peter D Fairclough, et al.
American Journal of Physiology. Cell Physiology|July 13, 2007
Microtubules are needed for the perinuclear positioning of aquaporin-2 after its endocytic retrieval in renal principal cellsAnna Vossenkämper, Pavel I Nedvetsky, Burkhard Wiesner, et al.
Gastroenterology|April 8, 2014
A CD3-specific antibody reduces cytokine production and alters phosphoprotein profiles in intestinal tissues from patients with inflammatory bowel diseaseAnna Vossenkämper, Christian Hundsrucker, Kevin Page, et al.
European Journal of Immunology|September 16, 2004
Both IL-12 and IL-18 contribute to small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii, but IL-12 is dominant over IL-18 in parasite controlAnna Vossenkämper, Daniela Struck, Cosme Alvarado-Esquivel, et al.
Journal of the American Society of Nephrology : JASN|August 21, 2010
Reciprocal regulation of aquaporin-2 abundance and degradation by protein kinase A and p38-MAP kinasePavel I Nedvetsky, Vedrana Tabor, Grazia Tamma, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2010
Inhibition of NF-κB signaling in human dendritic cells by the enteropathogenic Escherichia coli effector protein NleEAnna Vossenkämper, Olivier Marchès, Peter D Fairclough, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 2, 2013
Proinflammatory Vδ2+ T cells populate the human intestinal mucosa and enhance IFN-γ production by colonic αβ T cellsNeil E McCarthy, Zora Bashir, Anna Vossenkämper, et al.
Scientific Reports|March 23, 2018
Preclinical Development of a Novel, Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel DiseaseJ Scott Crowe, Kevin J Roberts, Timothy M Carlton, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Archivum Immunologiae Et Therapiae Experimentalis|July 27, 2011
Transitional B cells: how well are the checkpoints for specificity understood?Anna Vossenkämper, Jo Spencer
Journal of Inflammation (London, England)|May 5, 2011
Always one step ahead: How pathogenic bacteria use the type III secretion system to manipulate the intestinal mucosal immune systemAnna Vossenkämper, Thomas T Macdonald, Olivier Marchès
Journal of Pediatric Gastroenterology and Nutrition|December 3, 2011
Colonic lymphoid nodular hyperplasia in an adolescentAnna Vossenkämper, Asma Fikree, Peter D Fairclough, et al.
American Journal of Physiology. Cell Physiology|July 13, 2007
Microtubules are needed for the perinuclear positioning of aquaporin-2 after its endocytic retrieval in renal principal cellsAnna Vossenkämper, Pavel I Nedvetsky, Burkhard Wiesner, et al.
Gastroenterology|April 8, 2014
A CD3-specific antibody reduces cytokine production and alters phosphoprotein profiles in intestinal tissues from patients with inflammatory bowel diseaseAnna Vossenkämper, Christian Hundsrucker, Kevin Page, et al.
European Journal of Immunology|September 16, 2004
Both IL-12 and IL-18 contribute to small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii, but IL-12 is dominant over IL-18 in parasite controlAnna Vossenkämper, Daniela Struck, Cosme Alvarado-Esquivel, et al.
Journal of the American Society of Nephrology : JASN|August 21, 2010
Reciprocal regulation of aquaporin-2 abundance and degradation by protein kinase A and p38-MAP kinasePavel I Nedvetsky, Vedrana Tabor, Grazia Tamma, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2010
Inhibition of NF-κB signaling in human dendritic cells by the enteropathogenic Escherichia coli effector protein NleEAnna Vossenkämper, Olivier Marchès, Peter D Fairclough, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 2, 2013
Proinflammatory Vδ2+ T cells populate the human intestinal mucosa and enhance IFN-γ production by colonic αβ T cellsNeil E McCarthy, Zora Bashir, Anna Vossenkämper, et al.
Scientific Reports|March 23, 2018
Preclinical Development of a Novel, Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel DiseaseJ Scott Crowe, Kevin J Roberts, Timothy M Carlton, et al.
Pageof 3